BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 25434554)

  • 1. Chemical Composition and Skin-Whitening Activities of
    Lee DK; Won KJ; Kim DY; Kim YY; Lee HM
    Plants (Basel); 2023 Nov; 12(23):. PubMed ID: 38068567
    [No Abstract]   [Full Text] [Related]  

  • 2. Broussonin A- and B-mediated inhibition of angiogenesis by blockade of VEGFR-2 signalling pathways and integrin β1 expression.
    Kim JH; Kim S; Han S; Ahn EK; Cho YR; Jeong W; Kim SJ; Bae GU; Oh JS; Seo DW
    J Cell Mol Med; 2022 Feb; 26(4):1194-1205. PubMed ID: 34994065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant Compounds, Kirenol and Methyl ent-16α, 17-dihydroxy-kauran-19-oate Bioactivity-Guided Isolated from
    Shim SY; Lee YE; Lee M
    Molecules; 2021 Mar; 26(7):. PubMed ID: 33808322
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel functions for 2-phenylbenzimidazole-5-sulphonic acid: Inhibition of ovarian cancer cell responses and tumour angiogenesis.
    Kim MS; Kim JH; Ahn EK; Cho YR; Han S; Lee CH; Bae GU; Oh JS; Kim KB; Seo DW
    J Cell Mol Med; 2020 Feb; 24(4):2688-2700. PubMed ID: 31958895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma.
    Lin J; Cao S; Wang Y; Hu Y; Liu H; Li J; Chen J; Li P; Liu J; Wang Q; Zheng L
    J Exp Clin Cancer Res; 2018 Jun; 37(1):113. PubMed ID: 29866133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential oil from Siegesbeckia pubescens induces apoptosis through the mitochondrial pathway in human HepG2 cells.
    Lv D; Guo KW; Xu C; Huang M; Zheng SJ; Ma XH; Pan LH; Wang Q; Yang XZ
    J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):87-92. PubMed ID: 28224421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vitro antitumor activity of Siegesbeckia glabrescens against ovarian cancer through suppression of receptor tyrosine kinase expression and the signaling pathways.
    Cho YR; Choi SW; Seo DW
    Oncol Rep; 2013 Jul; 30(1):221-6. PubMed ID: 23673404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory effects of Siegesbeckia glabrescens on non-small cell lung cancer cell proliferation and invasion.
    Lee HN; Joo JH; Oh JS; Choi SW; Seo DW
    Am J Chin Med; 2014; 42(2):453-63. PubMed ID: 24707874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broussonetia kazinoki modulates the expression of VEGFR-2 and MMP-2 through the inhibition of ERK, Akt and p70S6K‑dependent signaling pathways: Its implication in endothelial cell proliferation, migration and tubular formation.
    Cho YR; Kim JH; Kim JK; Ahn EK; Ko HJ; In JK; Lee SJ; Bae GU; Kim YK; Oh JS; Seo DW
    Oncol Rep; 2014 Oct; 32(4):1531-6. PubMed ID: 25109823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coptis japonica Makino extract suppresses angiogenesis through regulation of cell cycle-related proteins.
    Kim SH; Kim EC; Kim WJ; Lee MH; Kim SY; Kim TJ
    Biosci Biotechnol Biochem; 2016 Jun; 80(6):1095-106. PubMed ID: 26924430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnolol suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting Ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways.
    Kim KM; Kim NS; Kim J; Park JS; Yi JM; Lee J; Bang OS
    Nutr Cancer; 2013; 65(8):1245-53. PubMed ID: 24066970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-angiogenic effects of Siegesbeckia glabrescens are mediated by suppression of the Akt and p70S6K-dependent signaling pathways.
    Kim HJ; Ko HY; Choi SW; Seo DW
    Oncol Rep; 2015 Feb; 33(2):699-704. PubMed ID: 25434554
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.